N. meningitidis 1681 is a member of the FinO family of RNA chaperones

Figures & data

Figure 1 X-ray crystal structure of NMB1681 reveals structural similarity to FinO. (A) Stereo view of an alignment of the six NMB1681 polypeptide chains in the crystallographic asymmetric unit. Alpha helices are numbered in accordance with the FinO numbering system. (B) Comparison of the structures of FinO (orange ribbon) and NMB1681 (blue ribbon) from two different orientations. Images in the top part are in the same orientation as in (A) whereas those in the bottom part are related to those in the top by a 180° rotation about the vertical axis. In each part, the left image shows a structural alignment of NMB1681 with FinO. Chain termini and secondary structure elements are labeled, as is residue 45 in FinO. Truncation of the region N-terminal to residue 45 does not reduce RNA binding activity but abolishes RNA strand exchange and duplexing activities. The middle and right images show the electrostatic surfaces of FinO (middle) and NMB1681 (right). (C) Structure-based sequence alignment of FinO, ProQ and NMB1681 with secondary structures indicated. Identical residues or residues with conserved charge are highlighted (orange, identical hydrophobic residues; red, conserved negatively charged residues; blue, conserved positively charged residues; green, identical hydrophilic residues).

Figure 2 RNA binding activity of NMB1681. (A) Electrophoretic gel mobility shift assays (EMSA) were used to assess interactions between NMB1681 and a double stranded RNA (SIIA/B, left part) or a single-stranded RNA (SIIA, right part). (B) Quantitation of EMSA results for the binding of NMB1681 to double stranded RNA (dsRNA). Fitting of the binding curves suggest NMB1681 binds dsRNA with a K_d of 36 ± 4 nM.

Figure 3 RNA strand exchange activity of NMB1681. (A) Schematic diagram of the strand exchange assay. A two-stranded mimic of FinP SLII (SIIA/B) in which the (A) strand is labeled with ³²P (*), is challenged with an excess of unlabeled SIIA. Exchange of the labeled SIIA from duplex to single strand is monitored by gel electrophoresis. (B) Strand exchange of NMB1681 was compared to FinO or a no protein control over a 180 min. time course utilizing continuous native gel electrophoresis. The positions of the duplex and single stranded species are indicated, as well as degradation species (*). (C) Using data from (B) (averaged from two independent experiments), the fraction of exchanged (released) SIIA was fit to a first order exponential giving rates of strand exchange of 0.032 ± 0.007 min⁻¹ and 0.011 ± 0.004 min⁻¹ for FinO and NMB1681 respectively.

Figure 4 RNA annealing activity of NMB1681. (A) Schematic diagram of the RNA duplexing assay. Stem-loop II from FinP (SLII) is labeled with ³²P (*) was incubated with an excess of unlabeled, complementary SLIIc from traJ mRNA. Duplex formation between these RNAs is monitored as a function of time by native gel electrophoresis. (B) Duplex formation between SLII and SLIIc RNAs is monitored over a 120 min. time course by continuous native gel electrophoresis, catalyzed by NMB1681, FinO or no protein control, as indicated. The positions of the hairpin and duplex forms of the RNAs are indicated as well as the position of an RNA degradation product (*). (C) Using data from (B) (from two independent experiments), the fraction of duplex formed was fit to a first order exponential giving rates of duplexing of 0.13 ± 0.03 min⁻¹ and 0.21 ± 0.05 min⁻¹ for FinO and NMB1681 respectively.

Figure 5 NMB1681 exhibits weak protection of FinP in vivo. FinP stability in E. coli cells was assessed at 0 and 120 min. following rifampicin treatment by northern blot analysis. FinP stabilities were compared between cells expressing either NMB1681, the N-terminal deletion mutant, NMB1681Δ, full length FinO or two N-terminal deletion mutants (FinO^26–186 and FinO^45–186), the control protein, TraD or the pBAD24 vector. The fraction of FinP protected at 120 min. post-rifampicin compared to the 0 min. time point was calculated after normalization to the tRNA^Ser loading control.

Table 1 Crystallographic statistics

Data collection	NMB1681
Space group	C2
Unit Cell (Å, °)	a = 126.5, b = 76.53, c = 122.7, β = 116.8
MW Da (no. of residues)	15500 (141)1
Number of molecules/AU	6
SeMet residues/AU	18
Wavelength (Å)	0.97932 (peak)
Resolution range (Å)	110–0.2.20 (2.25–2.20)2
Number of unique reflections	526273
Redundancy	4.1 (2.8)2
Completeness (%)	97.1 (79.2)2
Rmerge (%)	8.8 (46.4)2
I/σ(I)	26.7 (1.9)2
Phasing
RCullis (anomalous) (%)	80
Figure of merit (%)	18.6
Refinement
Resolution	43.0–2.20
Reflections (work/test)	96019/4882
Rcrystal/Rfree (%)	19.1/23.5
Rms deviation from ideal geometry Bond length (Å)/angle (°)	0.008/1.026
No. of protein atoms	5416
No. of Cryo/Water molecules	1/170
Mean B-value (Å2) (mainchain/sidechain)	55.7/62.6
Ramachandran plot statistic (%)
Residues in most favored regions	95.5
in additional allowed regions	4.5
in generously allowed regions	0.0
in disallowed region	0.0

1 Not including cloning artifact.

2 () indicates highest resolution shell.

3 Including Bijvoet pairs.

Table 2 Fertility inhibition of the F plasmid (pOX38-Km) by FinO or NMB1681 constructs

Plasmid	FinO	No protein	FinO^26–180	FinO^45–180	NMB1681	NMB1681Δ
Mating efficiency (T/D)1	2.5 × 10^−3	2 × 10^−1	3 × 10^−3	3 × 10^−1	2.5 × 10^−2	3.5 × 10^−2

1 Determined by assaying donor ability of cells containing an F derivative, pOX38-Km, and the corresponding pBAD24 expressing the indicated protein. T/D, transconjugants per donor.